Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1956 2
1959 2
1960 1
1961 2
1962 2
1963 3
1964 2
1965 2
1967 1
1968 2
1971 2
1978 2
1981 1
1983 1
1984 1
1985 2
1986 3
1987 7
1988 3
1989 4
1990 7
1991 4
1992 4
1993 7
1994 4
1995 6
1996 7
1997 17
1998 7
1999 5
2000 17
2001 16
2002 21
2003 20
2004 14
2005 12
2006 5
2007 28
2008 27
2009 38
2010 28
2011 30
2012 26
2013 17
2014 20
2015 34
2016 17
2017 39
2018 33
2019 31
2020 35
2021 31
2022 39
2023 19

Text availability

Article attribute

Article type

Publication date

Search Results

632 results

Results by year

Filters applied: . Clear all
Page 1
Deucravacitinib versus placebo and apremilast in moderate to severe plaque psoriasis: Efficacy and safety results from the 52-week, randomized, double-blinded, phase 3 Program fOr Evaluation of TYK2 inhibitor psoriasis second trial.
Strober B, Thaçi D, Sofen H, Kircik L, Gordon KB, Foley P, Rich P, Paul C, Bagel J, Colston E, Throup J, Kundu S, Sekaran C, Linaberry M, Banerjee S, Papp KA. Strober B, et al. Among authors: foley p. J Am Acad Dermatol. 2023 Jan;88(1):40-51. doi: 10.1016/j.jaad.2022.08.061. Epub 2022 Sep 14. J Am Acad Dermatol. 2023. PMID: 36115523 Free article. Clinical Trial.
Intravenous ferric derisomaltose in patients with heart failure and iron deficiency in the UK (IRONMAN): an investigator-initiated, prospective, randomised, open-label, blinded-endpoint trial.
Kalra PR, Cleland JGF, Petrie MC, Thomson EA, Kalra PA, Squire IB, Ahmed FZ, Al-Mohammad A, Cowburn PJ, Foley PWX, Graham FJ, Japp AG, Lane RE, Lang NN, Ludman AJ, Macdougall IC, Pellicori P, Ray R, Robertson M, Seed A, Ford I; IRONMAN Study Group. Kalra PR, et al. Among authors: foley pwx. Lancet. 2022 Dec 17;400(10369):2199-2209. doi: 10.1016/S0140-6736(22)02083-9. Epub 2022 Nov 5. Lancet. 2022. PMID: 36347265 Free article. Clinical Trial.
Clinical Management of Pain in Rodents.
Foley PL, Kendall LV, Turner PV. Foley PL, et al. Comp Med. 2019 Dec 1;69(6):468-489. doi: 10.30802/AALAS-CM-19-000048. Epub 2019 Dec 10. Comp Med. 2019. PMID: 31822323 Free PMC article. Review.
Phase 2 Trial of Selective Tyrosine Kinase 2 Inhibition in Psoriasis.
Papp K, Gordon K, Thaçi D, Morita A, Gooderham M, Foley P, Girgis IG, Kundu S, Banerjee S. Papp K, et al. Among authors: foley p. N Engl J Med. 2018 Oct 4;379(14):1313-1321. doi: 10.1056/NEJMoa1806382. Epub 2018 Sep 11. N Engl J Med. 2018. PMID: 30205746 Free article. Clinical Trial.
Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial.
Blauvelt A, de Bruin-Weller M, Gooderham M, Cather JC, Weisman J, Pariser D, Simpson EL, Papp KA, Hong HC, Rubel D, Foley P, Prens E, Griffiths CEM, Etoh T, Pinto PH, Pujol RM, Szepietowski JC, Ettler K, Kemény L, Zhu X, Akinlade B, Hultsch T, Mastey V, Gadkari A, Eckert L, Amin N, Graham NMH, Pirozzi G, Stahl N, Yancopoulos GD, Shumel B. Blauvelt A, et al. Among authors: foley p. Lancet. 2017 Jun 10;389(10086):2287-2303. doi: 10.1016/S0140-6736(17)31191-1. Epub 2017 May 4. Lancet. 2017. PMID: 28478972 Clinical Trial.
Class II malocclusion correction with Invisalign: Is it possible?
Patterson BD, Foley PF, Ueno H, Mason SA, Schneider PP, Kim KB. Patterson BD, et al. Among authors: foley pf. Am J Orthod Dentofacial Orthop. 2021 Jan;159(1):e41-e48. doi: 10.1016/j.ajodo.2020.08.016. Epub 2020 Nov 19. Am J Orthod Dentofacial Orthop. 2021. PMID: 33223374
Psoriasis and cancer. An Australian/New Zealand narrative.
Rademaker M, Rubel DM, Agnew K, Andrews M, Armour KS, Baker C, Foley P, Gebauer K, Goh MS, Gupta M, Marshman G, Prince HM, Sullivan J. Rademaker M, et al. Among authors: foley p. Australas J Dermatol. 2019 Feb;60(1):12-18. doi: 10.1111/ajd.12889. Epub 2018 Jul 10. Australas J Dermatol. 2019. PMID: 29992535 Free article. Review.
Psoriasis and infection. A clinical practice narrative.
Rademaker M, Agnew K, Anagnostou N, Andrews M, Armour K, Baker C, Foley P, Gebauer K, Gupta M, Marshman G, Rubel D, Sullivan J, Wong LC. Rademaker M, et al. Among authors: foley p. Australas J Dermatol. 2019 May;60(2):91-98. doi: 10.1111/ajd.12895. Epub 2018 Aug 5. Australas J Dermatol. 2019. PMID: 30079566 Review.
Effectiveness of an App and Provider Counseling for Obesity Treatment in Primary Care.
Bennett GG, Steinberg D, Askew S, Levine E, Foley P, Batch BC, Svetkey LP, Bosworth HB, Puleo EM, Brewer A, DeVries A, Miranda H. Bennett GG, et al. Among authors: foley p. Am J Prev Med. 2018 Dec;55(6):777-786. doi: 10.1016/j.amepre.2018.07.005. Epub 2018 Oct 22. Am J Prev Med. 2018. PMID: 30361140 Free PMC article. Clinical Trial.
Treat-to-Target in Atopic Dermatitis: An International Consensus on a Set of Core Decision Points for Systemic Therapies.
De Bruin-Weller M, Biedermann T, Bissonnette R, Deleuran M, Foley P, Girolomoni G, Hercogová J, Hong CH, Katoh N, Pink AE, Richard MA, Shumack S, Silvestre JF, Weidinger S. De Bruin-Weller M, et al. Among authors: foley p. Acta Derm Venereol. 2021 Feb 17;101(2):adv00402. doi: 10.2340/00015555-3751. Acta Derm Venereol. 2021. PMID: 33491094 Free PMC article.
632 results